> Last Item Added:
0 Items

Millipore Corporation named
Corporate Citizen of the Year

Corporate commitment to reduce global carbon footprint
through clean energy is lauded

Billerica, Massachusetts—November 12, 2009— Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry has been named “Corporate Citizen of the Year” by the New England Clean Energy Council. The company’s commitment to reducing its global carbon footprint was recognized as an outstanding achievement. Millipore President and CEO Martin Madaus, along with Director of EHS & Sustainability David Newman, accepted the award at the Council’s Green Tie Gala held last night at the John F. Kennedy Library and Museum in Boston.

Millipore staff attending the “Green Tie Gala” were, L to R: Property Manager Jim Flaherty, Director, Manufacturing Operations, Mitch Fonda, Regional Facilities Manager Paul Lukitsch; Corporate VP, Global Operations, Pete Kershaw; President and CEO Martin Madaus; Director of Sustainability David Newman; Property Manager Sal Monaco; EHS Engineer Johanna Jobin; VP, Strategy and Corporate Operations, Chris Barrile. Not shown: Director, Corporate Communications, Karen Marinella Hall.

The New England Clean Energy Council is comprised of many stakeholders, including clean energy companies, investors, financial institutions, local universities and colleges, and industry associations, and is focused on accelerating the region’s clean energy economy.

“Millipore is honored to receive this award from the New England Clean Energy Council,” said Madaus. “We firmly believe that as a multinational corporation, we have an opportunity and a responsibility to demonstrate environmental leadership through clean energy. Adopting environmentally friendly practices is not only the right thing to do—we see many business benefits from adopting energy efficiency initiatives and renewable energy technologies. It is my hope that more companies will start to transform by integrating sustainability principles into their operating practices, helping to mitigate the risks of global climate change we all face.”

In 2008, Millipore formally announced an ambitious multi-year environmental effort aimed at reducing the company’s global carbon footprint by 20 percent over five years. The company’s initiative encompasses a wide range of programs focused on dramatically reducing the company’s consumption of non-renewable resources, eliminating waste and adopting other changes that support long-term environmental sustainability.

A big part of its strategy to meet its carbon reduction goal is through the implementation of a comprehensive energy management program that includes a combination of energy efficiency and renewable energy projects. Most recently, the company completed a major solar panel installation at two of its Massachusetts facilities. Millipore is also an active participant in the Massachusetts Governor’s Clean Energy Challenge.

David Newman, Director of Millipore’s Sustainability Initiative, was also on hand to accept the award. “At Millipore, we take climate change and our responsibilities as a good corporate citizen very seriously. We set a goal a year and a half ago to reduce our greenhouse gas emissions by 20 percent over five years, and we plan to meet that while still growing our business. Already, through a combination of programs that save energy, drive down usage and even improve the reliability of our manufacturing processes, we have cut our energy use by 12 percent worldwide, and our greenhouse gas emissions by 15 percent.”

For more information about Millipore’s Sustainability Initiative, visit the Sustainability section of the company’s website: http://www.millipore.com/sustainability.

About Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 5,900 employees worldwide. For more information, visit www.millipore.com.

Research. Development. Production.

Safe Harbor Statement
Certain of the matters discussed herein, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.

Potential risks and uncertainties that could affect Millipore's future operating results include, without limitation, failure to achieve anticipate growth; failure to achieve anticipated returns on sustainability investments; failure to achieve design wins into our pharmaceutical and biotechnology customers’ manufacturing design phase for a particular drug or vaccine; delay, suspension or termination of a customer’s volume production; fluctuations in the timing of customers’ orders; lack of availability of raw materials or component products on a timely basis; regulatory delay in the approval of new therapeutics; limitations on cash flow for operations and investment due to debt service obligations; the inability to establish and maintain necessary product and process quality levels; reduced demand for cell culture products using bovine serum; the inability to realize the expected benefits of development, marketing, licensing and other alliances; competitive factors such as new membrane or chromatography technology; risks relating to our concentration of principal manufacturing operations; the inability to successfully integrate acquired businesses; the inability to utilize technology in current or planned products due to overriding rights by third parties; potential environmental liabilities; conditions in the economy in general and in the bioscience and bioprocess markets in particular; foreign exchange fluctuations; reduced private and government research funding; exposure to product liability claims; and difficulties inherent in transferring or outsourcing of manufacturing operations. Please refer to our filings with the SEC, including our most recent Annual Report on Form 10-K, for more information on these and other risks that could cause actual results to differ.

Millipore Media Contact:

Karen Marinella Hall
Director of Corporate Communications
Millipore Corporation
Office: 978-715-1567
Cell: 508-212-9476

Joshua Young
Director, Investor Relations
(978) 715-1527

Find A Location

Find the Millipore office or expert closest to you.

Contact Us

We want to hear from you. Contact a specific department below or click "Suggestions and Feedback" to send your comments.